3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one

C24H28N4O4S — CID 22157512

IUPAC3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one
SMILESCOc1ccc(N2CC(CN3CCC(n4c(=S)[nH]c5ccccc54)CC3)OC2=O)cc1OC
InChIInChI=1S/C24H28N4O4S/c1-30-21-8-7-17(13-22(21)31-2)27-15-18(32-24(27)29)14-26-11-9-16(10-12-26)28-20-6-4-3-5-19(20)25-23(28)33/h3-8,13,16,18H,9-12,14-15H2,1-2H3,(H,25,33)
InChIKeyPMBKRILDXAUMMW-UHFFFAOYSA-N
MW468.58 g/mol
LogP4.38
Rot. Bonds6

About 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one

3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one (PubChem CID 22157512) has the molecular formula C24H28N4O4S and a molecular weight of 468.58 g/mol. Its IUPAC name is 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one
PubChem CID22157512
Molecular FormulaC24H28N4O4S
Molecular Weight468.58 g/mol
Exact Mass468.18
IUPAC Name3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one
SMILESCOc1ccc(N2CC(CN3CCC(n4c(=S)[nH]c5ccccc54)CC3)OC2=O)cc1OC
InChIInChI=1S/C24H28N4O4S/c1-30-21-8-7-17(13-22(21)31-2)27-15-18(32-24(27)29)14-26-11-9-16(10-12-26)28-20-6-4-3-5-19(20)25-23(28)33/h3-8,13,16,18H,9-12,14-15H2,1-2H3,(H,25,33)
InChIKeyPMBKRILDXAUMMW-UHFFFAOYSA-N
XLogP4.38
TPSA71.96 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500468.58
LogP ≤ 54.38
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one?
The IUPAC name of 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one (CID 22157512) is 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one.
What is the SMILES notation for 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one?
The canonical SMILES for 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one is COc1ccc(N2CC(CN3CCC(n4c(=S)[nH]c5ccccc54)CC3)OC2=O)cc1OC.
What is the InChIKey of 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one?
The InChIKey is PMBKRILDXAUMMW-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H28N4O4S/c1-30-21-8-7-17(13-22(21)31-2)27-15-18(32-24(27)29)14-26-11-9-16(10-12-26)28-20-6-4-3-5-19(20)25-23(28)33/h3-8,13,16,18H,9-12,14-15H2,1-2H3,(H,25,33).
What are the key properties of 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one?
3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one has a molecular weight of 468.58 g/mol, XLogP of 4.38, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3,4-dimethoxyphenyl)-5-[[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]-1,3-oxazolidin-2-one is sourced from PubChem (CID 22157512), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).